Immunogenicity and Safety of the Quadrivalent Adjuvant Subunit Influenza Vaccine in Seropositive and Seronegative Healthy People and Patients with Common Variable Immunodeficiency

Background. Influenza prophylaxis with the use of quadrivalent vaccines (QIV) is increasingly being introduced into healthcare practice. Methods. In total, 32 healthy adults and 6 patients with common variable immunodeficiency (CVID) received adjuvant QIV during 2018–2019 influenza season. Depending...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής

Κύριοι συγγραφείς:	Mikhail P. Kostinov, Elena A. Latysheva, Aristitsa M. Kostinova, Nelly K. Akhmatova, Tatyana V. Latysheva, Anna E. Vlasenko, Yulia A. Dagil, Ekaterina A. Khromova, Valentina B. Polichshuk
Μορφή:	Artigo
Γλώσσα:	Inglês
Έκδοση:	MDPI AG 2020-11-01
Σειρά:	Vaccines
Θέματα:	adjuvanted QIV immunogenicity influenza seropositive/seronegative CVID azoximer bromide
Διαθέσιμο Online:	https://www.mdpi.com/2076-393X/8/4/640
Ετικέτες:	Προσθήκη ετικέτας Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!